Möricke A - Search Results

1

Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.

Tamm R, Mägi R, Tremmel R, Winter S, Mihailov E, Smid A, Möricke A, Klein K, Schrappe M, Stanulla M, Houlston R, Weinshilboum R, Mlinarič Raščan I, Metspalu A, Milani L, Schwab M, Schaeffeler E. Tamm R, et al. Among authors: moricke a. Clin Pharmacol Ther. 2017 May;101(5):684-695. doi: 10.1002/cpt.540. Epub 2017 Feb 1. Clin Pharmacol Ther. 2017. PMID: 27770449 Free PMC article. Review.

2

Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL.

Locatelli F, Zugmaier G, Rizzari C, Morris JD, Gruhn B, Klingebiel T, Parasole R, Linderkamp C, Flotho C, Petit A, Micalizzi C, Zeng Y, Desai R, Kormany WN, Eckert C, Möricke A, Sartor M, Hrusak O, Peters C, Saha V, Vinti L, von Stackelberg A. Locatelli F, et al. Among authors: moricke a. Leukemia. 2023 Jan;37(1):222-225. doi: 10.1038/s41375-022-01770-3. Epub 2022 Dec 8. Leukemia. 2023. PMID: 36482128 Free PMC article. No abstract available.

3

The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia.

Meissner B, Stanulla M, Ludwig WD, Harbott J, Möricke A, Welte K, Schrappe M. Meissner B, et al. Among authors: moricke a. Leukemia. 2004 Nov;18(11):1920-3. doi: 10.1038/sj.leu.2403521. Leukemia. 2004. PMID: 15457183 No abstract available.

4

Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M. Möricke A, et al. Klin Padiatr. 2005 Nov-Dec;217(6):310-20. doi: 10.1055/s-2005-872515. Klin Padiatr. 2005. PMID: 16307416

5

Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.

Stanulla M, Cario G, Meissner B, Schrauder A, Möricke A, Riehm H, Schrappe M. Stanulla M, et al. Among authors: moricke a. Blood Cells Mol Dis. 2007 Sep-Oct;39(2):160-3. doi: 10.1016/j.bcmd.2007.04.005. Epub 2007 May 25. Blood Cells Mol Dis. 2007. PMID: 17532236 Review.

6

High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.

Cario G, Izraeli S, Teichert A, Rhein P, Skokowa J, Möricke A, Zimmermann M, Schrauder A, Karawajew L, Ludwig WD, Welte K, Schünemann HJ, Schlegelberger B, Schrappe M, Stanulla M. Cario G, et al. Among authors: moricke a. J Clin Oncol. 2007 Oct 20;25(30):4813-20. doi: 10.1200/JCO.2007.11.8166. J Clin Oncol. 2007. PMID: 17947730

7

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M; German-Austrian-Swiss ALL-BFM Study Group. Möricke A, et al. Blood. 2008 May 1;111(9):4477-89. doi: 10.1182/blood-2007-09-112920. Epub 2008 Feb 19. Blood. 2008. PMID: 18285545 Free article. Clinical Trial.

8

Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.

Cario G, Fetz A, Bretscher C, Möricke A, Schrauder A, Stanulla M, Schrappe M. Cario G, et al. Among authors: moricke a. Ann Hematol. 2008 Sep;87(9):709-16. doi: 10.1007/s00277-008-0504-x. Epub 2008 Jun 3. Ann Hematol. 2008. PMID: 18521602

9

Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.

Schwarz AK, Stanulla M, Cario G, Flohr T, Sutton R, Möricke A, Anker P, Stroun M, Welte K, Bartram CR, Schrappe M, Schrauder A. Schwarz AK, et al. Among authors: moricke a. Ann Hematol. 2009 Sep;88(9):897-905. doi: 10.1007/s00277-009-0698-6. Epub 2009 Jan 23. Ann Hematol. 2009. PMID: 19165483 Free article.

10

Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study.

Kidas E, Möricke A, Beier R, Welte K, Schrappe M, Stanulla M, Grigull L. Kidas E, et al. Among authors: moricke a. Int J Hematol. 2009 Jun;89(5):584-91. doi: 10.1007/s12185-009-0285-6. Epub 2009 Apr 8. Int J Hematol. 2009. PMID: 19353239 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page